{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:26:24Z","timestamp":1793384784519,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme under the Marie Sk\u0142odowska-Curie","award":["No 813781"],"award-info":[{"award-number":["No 813781"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme under the Marie Sk\u0142odowska-Curie","award":["No 813781"],"award-info":[{"award-number":["No 813781"]}]},{"name":"The Novo Nordisk Foundation, Challenge programme, CAMiT","award":["NNF17CO0028232"],"award-info":[{"award-number":["NNF17CO0028232"]}]},{"name":"The Novo Nordisk Foundation, Challenge programme, CAMiT","award":["NNF17CO0028232"],"award-info":[{"award-number":["NNF17CO0028232"]}]},{"name":"The Novo Nordisk Foundation, Challenge programme, CAMiT","award":["NNF17CO0028232"],"award-info":[{"award-number":["NNF17CO0028232"]}]},{"name":"The Novo Nordisk Foundation, Challenge programme, CAMiT","award":["NNF17CO0028232"],"award-info":[{"award-number":["NNF17CO0028232"]}]},{"name":"The Novo Nordisk Foundation, Challenge programme, CAMiT","award":["NNF17CO0028232"],"award-info":[{"award-number":["NNF17CO0028232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mouse models are commonly used to study the colonisation profiles of microorganisms introduced to the gastrointestinal tract. Three commonly used mouse models include conventional, germ-free, and antibiotic-treated mice. However, colonisation resistance in conventional mice and specialised equipment for germ-free mice are usually limiting factors in their applications. In this study, we sought to establish a robust colonisation model for\n                    <jats:italic>Saccharomyces boulardii<\/jats:italic>\n                    , a probiotic yeast that has caught attention in the field of probiotics and advanced microbiome therapeutics. We characterised the colonisation of\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    in conventional mice and mice treated with a cocktail of broad-spectrum antibiotics, including ampicillin, kanamycin, metronidazole and vancomycin. We found colonisation levels increased up to 10,000-fold in the antibiotic-treated mice compared to nonantibiotic-treated mice. Furthermore,\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    was detected continuously in more than 75% of mice for 10\u00a0days after the last administration in antibiotic-treated mice, in contrast to in nonantibiotic-treated mice where\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    was undetectable in less than 2\u00a0days. Finally, we demonstrated that this antibiotic cocktail can be used in two commonly used mouse strains, C57BL\/6 and\n                    <jats:italic>ob\/ob<\/jats:italic>\n                    mice, both achieving\u2009~\u200910\n                    <jats:sup>8<\/jats:sup>\n                    \u00a0CFU\/g of\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    in faeces. These findings highlight that the antibiotic cocktail used in this study is an advantageous tool to study\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    based probiotic and advanced microbiome therapeutics\n                    <jats:italic>.<\/jats:italic>\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-12806-0","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:08:37Z","timestamp":1653473317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract"],"prefix":"10.1038","volume":"12","author":[{"given":"Karl Alex","family":"Hedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Emily","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vazquez-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Otto Alexander","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"12806_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).","journal-title":"PLoS Biol."},{"issue":"7402","key":"12806_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"C Huttenhower","year":"2012","unstructured":"Huttenhower, C. et al. Structure, function and diversity of the healthy human microbiome. Nature 486(7402), 207\u2013214 (2012).","journal-title":"Nature"},{"key":"12806_CR3","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3389\/fmicb.2018.01619","volume":"9","author":"Z Ma","year":"2018","unstructured":"Ma, Z., Li, L. & Li, W. Assessing and interpreting the within-body biogeography of human microbiome diversity. Front. Microbiol. 9, 1619 (2018).","journal-title":"Front. Microbiol."},{"key":"12806_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-018-0515-8","volume":"10","author":"R Kolde","year":"2018","unstructured":"Kolde, R. et al. Host genetic variation and its microbiome interactions within the Human Microbiome Project. Genome Med. 10, 1\u201313 (2018).","journal-title":"Genome Med."},{"key":"12806_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1756283X13482996","volume":"6","author":"CM Guinane","year":"2013","unstructured":"Guinane, C. M. & Cotter, P. D. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 6, 295\u2013308 (2013).","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"1","key":"12806_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41367-019-0011-7","volume":"9","author":"G Muscogiuri","year":"2019","unstructured":"Muscogiuri, G. et al. Gut microbiota: a new path to treat obesity. Int. J Obes. Suppl. 9(1), 10\u201319 (2019).","journal-title":"Int. J Obes. Suppl."},{"key":"12806_CR7","doi-asserted-by":"crossref","unstructured":"Das, T. et al. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy. Sci. Rep. 11, 2738 (123AD).","DOI":"10.1038\/s41598-021-82538-0"},{"key":"12806_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00811-2","volume":"8","author":"Y Heshiki","year":"2020","unstructured":"Heshiki, Y. et al. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 8, 1\u201314 (2020).","journal-title":"Microbiome"},{"key":"12806_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.trecan.2020.01.004","volume":"6","author":"JB Xavier","year":"2020","unstructured":"Xavier, J. B. et al. The cancer microbiome: distinguishing direct and indirect effects requires a systemic view. Trends Cancer 6, 192\u2013204 (2020).","journal-title":"Trends Cancer"},{"key":"12806_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fncel.2021.698172","volume":"15","author":"MA Sch\u00e4chtle","year":"2021","unstructured":"Sch\u00e4chtle, M. A. & Rosshart, S. P. The microbiota-gut-brain axis in health and disease and its implications for translational research. Front. Cell. Neurosci. 15, 256 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"12806_CR11","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1002\/jcph.1121","volume":"58","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Tran, D. Q. & Rhoads, J. M. Probiotics in disease prevention and treatment. J. Clin. Pharmacol. 58, S164\u2013S179 (2018).","journal-title":"J. Clin. Pharmacol."},{"key":"12806_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/apt.14173","volume":"46","author":"SP Costello","year":"2017","unstructured":"Costello, S. P. et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment. Pharmacol. Ther. 46, 213\u2013224 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"12806_CR13","doi-asserted-by":"publisher","first-page":"175628482093431","DOI":"10.1177\/1756284820934315","volume":"13","author":"B Barberio","year":"2020","unstructured":"Barberio, B. et al. Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital. Ther. Adv. Gastroenterol. 13, 1756284820934315 (2020).","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"5","key":"12806_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2(5), 1\u20136 (2017).","journal-title":"Nat. Microbiol."},{"key":"12806_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","volume":"105","author":"M Mimee","year":"2016","unstructured":"Mimee, M., Citorik, R. J. & Lu, T. K. Microbiome therapeutics\u2014advances and challenges. Adv. Drug Deliv. Rev. 105, 44\u201354 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"12806_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella, V. M. et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36(9), 857\u2013864 (2018).","journal-title":"Nat. Biotechnol."},{"key":"12806_CR17","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1126\/scitranslmed.aau7975","volume":"11","author":"CB Kurtz","year":"2019","unstructured":"Kurtz, C. B. et al. An engineered E. Coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11, 7975 (2019).","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"12806_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37373-1","volume":"9","author":"LS May-Zhang","year":"2019","unstructured":"May-Zhang, L. S. et al. Administration of N-Acyl-Phosphatidylethanolamine expressing bacteria to low density lipoprotein receptor\u2212\/\u2212 mice improves indices of cardiometabolic disease. Sci. Rep. 9(1), 1\u201313 (2019).","journal-title":"Sci. Rep."},{"key":"12806_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tibtech.2018.09.005","volume":"37","author":"DB Pedrolli","year":"2019","unstructured":"Pedrolli, D. B. et al. Engineering microbial living therapeutics: the synthetic biology toolbox. Trends Biotechnol. 37, 100\u2013115 (2019).","journal-title":"Trends Biotechnol."},{"key":"12806_CR20","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1007\/s11095-014-1430-3","volume":"31","author":"P Agarwal","year":"2014","unstructured":"Agarwal, P., Khatri, P., Billack, B., Low, W. K. & Shao, J. Oral delivery of Glucagon like peptide-1 by a recombinant Lactococcus lactis. Pharm. Res. 31, 3404\u20133414 (2014).","journal-title":"Pharm. Res."},{"key":"12806_CR21","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2337\/db13-1236","volume":"63","author":"S Robert","year":"2014","unstructured":"Robert, S. et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63, 2876\u20132887 (2014).","journal-title":"Diabetes"},{"key":"12806_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1172\/JCI60530","volume":"122","author":"T Takiishi","year":"2012","unstructured":"Takiishi, T. et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J. Clin. Investig. 122, 1717 (2012).","journal-title":"J. Clin. Investig."},{"key":"12806_CR23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2337\/db14-0635","volume":"64","author":"FF Duan","year":"2015","unstructured":"Duan, F. F., Liu, J. H. & March, J. C. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes 64, 1794\u20131803 (2015).","journal-title":"Diabetes"},{"key":"12806_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3389\/fmicb.2018.00723","volume":"9","author":"G Bagherpour","year":"2018","unstructured":"Bagherpour, G. et al. Oral administration of recombinant Saccharomyces boulardii expressing ovalbumin-CPE fusion protein induces antibody response in mice. Front. Microbiol. 9, 723 (2018).","journal-title":"Front. Microbiol."},{"key":"12806_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00109-020-01987-8","volume":"98","author":"CH Liu","year":"2020","unstructured":"Liu, C. H., Chang, J. H., Chang, Y. C. & Mou, K. Y. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. J. Mol. Med. (Berl) 98, 1675\u20131687 (2020).","journal-title":"J. Mol. Med. (Berl)"},{"key":"12806_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1021\/acssynbio.0c00562","volume":"10","author":"D Durmusoglu","year":"2021","unstructured":"Durmusoglu, D. et al. In situ biomanufacturing of small molecules in the Mammalian gut by probiotic Saccharomyces boulardii. ACS Synth. Biol. 10, 1039\u20131052 (2021).","journal-title":"ACS Synth. Biol."},{"key":"12806_CR27","doi-asserted-by":"crossref","unstructured":"Everard, A., Matamoros, S., Geurts, L., Delzenne, N. M. & Cani, P. D. Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db\/db Mice. mBio 5(3), e01011\u201314 (2014).","DOI":"10.1128\/mBio.01011-14"},{"key":"12806_CR28","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202","volume":"16","author":"LV McFarland","year":"2010","unstructured":"McFarland, L. V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. WJG 16, 2202 (2010).","journal-title":"World J. Gastroenterol. WJG"},{"key":"12806_CR29","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/0016-5085(93)90280-P","volume":"104","author":"C Pothoulakis","year":"1993","unstructured":"Pothoulakis, C. et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104, 1108\u20131115 (1993).","journal-title":"Gastroenterology"},{"key":"12806_CR30","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1128\/iai.64.12.5225-5232.1996","volume":"64","author":"I Castagliuolo","year":"1996","unstructured":"Castagliuolo, I., Thomas Lamont, J., Nikulasson, S. T. & Pothoulakis, C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect. Immun. 64, 5225 (1996).","journal-title":"Infect. Immun."},{"key":"12806_CR31","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1053\/j.gastro.2006.10.001","volume":"131","author":"G Dalmasso","year":"2006","unstructured":"Dalmasso, G. et al. Saccharomyces boulardii Inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131, 1812\u20131825 (2006).","journal-title":"Gastroenterology"},{"key":"12806_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1756283X11428502","volume":"5","author":"T Kelesidis","year":"2012","unstructured":"Kelesidis, T. & Pothoulakis, C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Ther. Adv. Gastroenterol. 5, 111 (2012).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"12806_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112660","volume":"9","author":"LE Hudson","year":"2014","unstructured":"Hudson, L. E. et al. Functional Heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii. PLoS ONE 9, e112660 (2014).","journal-title":"PLoS ONE"},{"key":"12806_CR34","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1128\/AEM.00057-16","volume":"82","author":"JJ Liu","year":"2016","unstructured":"Liu, J. J. et al. Metabolic engineering of probiotic Saccharomyces boulardii. Appl. Environ. Microbiol. 82, 2280 (2016).","journal-title":"Appl. Environ. Microbiol."},{"key":"12806_CR35","doi-asserted-by":"crossref","unstructured":"Khatri, I., Tomar, R., Ganesan, K., Prasad, G. S. & Subramanian, S. Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii. Sci. Rep. 7(1), 1\u201312 (2017).","DOI":"10.1038\/s41598-017-00414-2"},{"key":"12806_CR36","doi-asserted-by":"publisher","first-page":"e0153351","DOI":"10.1371\/journal.pone.0153351","volume":"11","author":"LE Hudson","year":"2016","unstructured":"Hudson, L. E. et al. Characterization of the probiotic yeast Saccharomyces boulardii in the healthy mucosal immune system. PLoS ONE 11, e0153351 (2016).","journal-title":"PLoS ONE"},{"key":"12806_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ibd.23006","volume":"19","author":"S Michael","year":"2013","unstructured":"Michael, S. et al. Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging. Inflamm. Bowel Dis. 19, 185\u2013193 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"12806_CR38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00109-020-01987-8","volume":"98","author":"CH Liu","year":"2020","unstructured":"Liu, C. H., Chang, J. H., Chang, Y. C. & Mou, K. Y. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. J. Mol. Med. 98, 1675\u20131687 (2020).","journal-title":"J. Mol. Med."},{"key":"12806_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/bdd.2510100403","volume":"10","author":"H Blehaut","year":"1989","unstructured":"Blehaut, H., Massot, J., Elmer, G. W. & Levy, R. H. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm. Drug Dispos. 10, 353\u2013364 (1989).","journal-title":"Biopharm. Drug Dispos."},{"key":"12806_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1126\/scitranslmed.aax4905","volume":"12","author":"K Chen","year":"2020","unstructured":"Chen, K. et al. A probiotic yeast-based immunotherapy against Clostridioides difficile infection. Sci. Transl. Med. 12, 567 (2020).","journal-title":"Sci. Transl. Med."},{"key":"12806_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1139\/w04-050","volume":"50","author":"JLR Fietto","year":"2011","unstructured":"Fietto, J. L. R. et al. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can. J. Microbiol. 50, 615\u2013621 (2011).","journal-title":"Can. J. Microbiol."},{"key":"12806_CR42","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1128\/AEM.02201-06","volume":"73","author":"L Edwards-Ingram","year":"2007","unstructured":"Edwards-Ingram, L. et al. Genotypic and physiological characterization of saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol. 73, 2458 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"12806_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/laban.1222","volume":"46","author":"CL Franklin","year":"2017","unstructured":"Franklin, C. L. & Ericsson, A. C. Microbiota and reproducibility of rodent models. Lab. Anim. NY 46, 114 (2017).","journal-title":"Lab. Anim. NY"},{"key":"12806_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-02018-9","volume":"20","author":"P Tirelle","year":"2020","unstructured":"Tirelle, P. et al. Comparison of different modes of antibiotic delivery on gut microbiota depletion efficiency and body composition in mouse. BMC Microbiol. 20, 1\u201310 (2020).","journal-title":"BMC Microbiol."},{"key":"12806_CR45","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3389\/fphys.2018.01534","volume":"9","author":"EA Kennedy","year":"2018","unstructured":"Kennedy, E. A., King, K. Y. & Baldridge, M. T. Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front. Physiol. 9, 1534 (2018).","journal-title":"Front. Physiol."},{"key":"12806_CR46","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.cell.2015.10.048","volume":"163","author":"M Levy","year":"2015","unstructured":"Levy, M. et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163, 1428\u20131443 (2015).","journal-title":"Cell"},{"key":"12806_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5625\/lar.2017.33.2.119","volume":"33","author":"HK Song","year":"2017","unstructured":"Song, H. K. & Hwang, D. Y. Use of C57BL\/6N mice on the variety of immunological researches. Lab. Anim. Res. 33, 119 (2017).","journal-title":"Lab. Anim. Res."},{"key":"12806_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/oxfordjournals.jhered.a106073","volume":"41","author":"AM Ingalls","year":"1950","unstructured":"Ingalls, A. M., Dickie, M. M. & Snell, G. D. Obese, a new mutation in the house mouse*. J. Hered. 41, 317\u2013318 (1950).","journal-title":"J. Hered."},{"key":"12806_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5455\/javar.2020.g399","volume":"7","author":"JB Suleiman","year":"2020","unstructured":"Suleiman, J. B., Mohamed, M. & Bakar, A. B. A. A systematic review on different models of inducing obesity in animals: advantages and limitations. J. Adv. Vet. An. Res. 7, 103 (2020).","journal-title":"J. Adv. Vet. An. Res."},{"key":"12806_CR50","first-page":"29","volume":"4","author":"N Matsuo","year":"2010","unstructured":"Matsuo, N. et al. Behavioral profiles of three C57BL\/6 substrains. Front. Behav. Neurosci. 4, 29 (2010).","journal-title":"Front. Behav. Neurosci."},{"key":"12806_CR51","first-page":"10","volume":"0","author":"C Kiselycznyk","year":"2011","unstructured":"Kiselycznyk, C. & Holmes, A. All (C57BL\/6) mice are not created equal. Front. Neurosci. 0, 10 (2011).","journal-title":"Front. Neurosci."},{"issue":"7","key":"12806_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41684-021-00777-0","volume":"50","author":"LL Long","year":"2021","unstructured":"Long, L. L. et al. Shared and distinctive features of the gut microbiome of C57BL\/6 mice from different vendors and production sites, and in response to a new vivarium. Lab Anim. 50(7), 185\u2013195 (2021).","journal-title":"Lab Anim."},{"issue":"2","key":"12806_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/cmi.2015.09","volume":"13","author":"H Kozakova","year":"2015","unstructured":"Kozakova, H. et al. Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell. Mol. Immunol. 13(2), 251\u2013262 (2015).","journal-title":"Cell. Mol. Immunol."},{"key":"12806_CR54","doi-asserted-by":"publisher","unstructured":"Conway, T., Krogfelt, K. A. & Cohen, P. S. The life of commensal Escherichia coli in the mammalian intestine. EcoSal Plus 1(1). https:\/\/doi.org\/10.1128\/ecosalplus.8.3.1.2 (2004).","DOI":"10.1128\/ecosalplus.8.3.1.2"},{"key":"12806_CR55","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1128\/IAI.02943-14","volume":"83","author":"SAC Schinner","year":"2015","unstructured":"Schinner, S. A. C. et al. Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917. Infect. Immun. 83, 1983\u20131991 (2015).","journal-title":"Infect. Immun."},{"key":"12806_CR56","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1128\/IAI.00006-09","volume":"77","author":"A Croswell","year":"2009","unstructured":"Croswell, A., Amir, E., Teggatz, P., Barman, M. & Salzman, N. H. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric salmonella infection. Infect. Immun. 77, 2741 (2009).","journal-title":"Infect. Immun."},{"key":"12806_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00899-6","volume":"8","author":"B Seelbinder","year":"2020","unstructured":"Seelbinder, B. et al. Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria. Microbiome 8, 1\u201320 (2020).","journal-title":"Microbiome"},{"issue":"5","key":"12806_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6(5), 343\u2013345 (2009).","journal-title":"Nat. Methods"},{"key":"12806_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2144\/000113672","volume":"50","author":"M L\u00f5oke","year":"2011","unstructured":"L\u00f5oke, M., Kristjuhan, K. & Kristjuhan, A. Extraction of genomic DNA from yeasts for PCR-based applications. Biotechniques 50, 325 (2011).","journal-title":"Biotechniques"},{"key":"12806_CR60","first-page":"107","volume":"313","author":"RD Gietz","year":"2006","unstructured":"Gietz, R. D. & Woods, R. A. Yeast transformation by the LiAc\/SS carrier DNA\/PEG method. Methods Mol. Biol. 313, 107\u2013120 (2006).","journal-title":"Methods Mol. Biol."},{"key":"12806_CR61","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert, N. P. et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 18, e3000411 (2020).","journal-title":"PLOS Biol."},{"key":"12806_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/femsre\/fuv036","volume":"40","author":"D Laukens","year":"2016","unstructured":"Laukens, D., Brinkman, B. M., Raes, J., de Vos, M. & Vandenabeele, P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol. Rev. 40, 117\u2013132 (2016).","journal-title":"FEMS Microbiol. Rev."},{"key":"12806_CR63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/nar\/29.1.181","volume":"29","author":"JA Klappenbach","year":"2001","unstructured":"Klappenbach, J. A., Saxman, P. R., Cole, J. R. & Schmidt, T. M. rrndb: the ribosomal RNA operon copy number database. Nucleic Acids Res. 29, 181 (2001).","journal-title":"Nucleic Acids Res."},{"key":"12806_CR64","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1111\/j.1365-294X.2010.04898.x","volume":"19","author":"AS Amend","year":"2010","unstructured":"Amend, A. S., Seifert, K. A. & Bruns, T. D. Quantifying microbial communities with 454 pyrosequencing: does read abundance count?. Mol. Ecol. 19, 5555\u20135565 (2010).","journal-title":"Mol. Ecol."},{"key":"12806_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.funeco.2012.10.002","volume":"6","author":"P Baldrian","year":"2013","unstructured":"Baldrian, P. et al. Estimation of fungal biomass in forest litter and soil. Fungal Ecol. 6, 1\u201311 (2013).","journal-title":"Fungal Ecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12806-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:50:13Z","timestamp":1669330213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12806-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12806-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"14 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8862"}}